Skip to content

To study the utility of oral detrose gel in reducing NICU admission of babies, in the first 2 days of life who develop low sugars and are given intravenous dextrose in the NICU.

Detrose gel in the management of asymptomatic hypogycemia in at-risk neonates: randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/11/010383
Enrollment
284
Registered
2017-11-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- asymptomatic neonates in the first 48 hours of life

Interventions

Intervention1: 40% oral dextrose gel: Approved by British National Formulary for treating hypoglycemia in children with diabetes mellitus. The standard dose used in neonates with hypoglycemia is 200mg

Sponsors

Neocore research fund
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Late preterms (born at 34weeks or more as per the LMP/ dating scan) 2. Term at-risk babies : a. SGA/IUGR (as per fenton growth chart) b. LGA (as per fenton growth chart) c.Infant of a diabetic mother

Exclusion criteria

Exclusion criteria: 1.Babies whoâ??re being admitted to NICU for any medical reason. 2.Babies started on intravenous fluids as per physicianâ??s discretion

Design outcomes

Primary

MeasureTime frame
To compare the need for NICU admission and parenteral fluids in the first 48 hours of life in the study group versus the control groupTimepoint: at 48 hours of life, each neonate included in the study will be assessed. final assessment in january 2019

Secondary

MeasureTime frame
to compare the number of babies on exclusive breast feeds at discharge in the study group versus in the control groupTimepoint: Birth to 48 hours of life

Countries

India

Contacts

Public ContactKirti Gupta

Sri Ramachandra university Porur Chennai

drprakash1@gmail.com9791181566

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026